TI
ABBV icon

Tidal Investments’s AbbVie ABBV Stock Holding History

Tidal Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,100
Closed -$251K – 2336
2025
Q4 		$251K Buy
+1,100
New +$251K ﹤0.01% 1918
2025
Q1 		– Sell
-2
Closed -$10 – 1825
2024
Q4 		$10 Buy
+2
New +$368 ﹤0.01% 1846

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tidal Investments's ABBV Position: Q1 2026 in Review

Tidal Investments increased its AbbVie (ABBV) stake by 149% in Q1 2026, buying an estimated $66.1M and bringing the position to 497,947 shares worth $107M. The position accounts for 0.23% of the portfolio, ranked #95.

Tidal Investments first reported a position in ABBV in Q3 2019 and has held it in 27 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Tidal Investments held 497,947 shares of AbbVie worth $107M as of Q1 2026.
  • Tidal Investments bought 297,845 AbbVie shares in Q1 2026, an estimated $66.1M.
  • AbbVie made up 0.23% of Tidal Investments's portfolio in Q1 2026, its #95 holding.
  • Tidal Investments first reported a position in AbbVie in Q3 2019 and has held it in 27 quarters since.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.